COVID-19 & CancerFreeGuest Editorial COVID-19 and community cancer careA Panorama of a Catastrophe May 08, 2020Vol.46 No.19By Debra Patt and Michael Kolodziej
Free Dafna Bar-Sagi, Arul Chinnaiyan, Carl June, Christopher Lima, Miriam Merad, and John Schiller are among newly elected NAS members May 01, 2020Vol.46 No.18
COVID-19 & CancerFreeGuest Editorial Cancer doesn’t wait—we are treating cancer patients now May 01, 2020Vol.46 No.18By Richard Bold and Timothy Donahue
COVID-19 & CancerFreeGuest Editorial The pandemic of COVID-19 and its effect on clinical trials in the communityHow do we move forward? May 01, 2020Vol.46 No.18By James N. Atkins
COVID-19 & CancerFreeGuest Editorial Under the onslaughts of COVID-19, Montefiore deployed a PPE strategy for patients—PREVENT/PROTECT/ENABLE May 01, 2020Vol.46 No.18By Balazs Halmos, Roman Perez-Soler, Stuart Packer, Mary G. LaRocca, Bruce Rapkin, Shalom Kalnicki and Joseph Sparano
Conversation with The Cancer LetterCOVID-19 & CancerFree With 61,000 people registered, first-ever virtual AACR annual meeting “enthusiastically received” May 01, 2020Vol.46 No.18By Alexandria Carolan
COVID-19 & CancerFree Remdesivir established as standard of care for COVID-19, Fauci declaresFDA issues Emergency Use Authorization May 01, 2020Vol.46 No.18By Matthew Bin Han Ong and Paul Goldberg
COVID-19 & CancerFree AACR data from China and Europe amount to “two different messages” for cancer patients with COVID-19 May 01, 2020Vol.46 No.18By Alexandria Carolan
Conversation with The Cancer LetterCOVID-19 & CancerFree Skip Burris: These few months are going to shape health care in the coming years May 01, 2020Vol.46 No.18By Paul Goldberg
